📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
151,859
All-time analysed
43,535
Positive
6,743
Negative
92,744
Neutral
8,769
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
270 announcements match the current filters (relevance ≥ 5).
Prostarm Q3 FY26 Revenue Jumps 110% to ₹161 Cr; Order Book Robust at ₹946 Cr
Prostarm Info Systems reported a massive 110% YoY revenue growth in Q3 FY26, reaching INR 161 crores, driven by large-scale project executions. The company's order book stands at a robust INR 946 crores, providing strong visibility for the next 18 months. Profitability also saw a significant jump, with PAT rising 101% YoY to INR 15 crores. Additionally, the company has become effectively net debt-free and is nearing the commissioning of a 1.2 GW BESS facility in Jhajjar.
Key Highlights
Q3 FY26 revenue grew 110% YoY to ₹161 crores, with PAT increasing 101% to ₹15 crores.
Current order book stands at ₹946 crores across 91 projects, with an additional ₹775 crores in the bid pipeline.
Long-term debt reduced to ₹1.5 crores, making the company effectively net debt-free.
New 1.2 GW BESS manufacturing facility in Jhajjar is expected to be operational by Q4 FY26.
Management guides for 20-25% revenue growth for the full year FY26.
👀 What to Watch
Investors should monitor the commissioning of the Jhajjar BESS facility and the execution of the large order book, which represents over 3x the current 9M revenue. The stock remains attractive due to its net debt-free status and strong growth trajectory in the energy storage sector.
Prostarm Q3 FY26 PAT Doubles to ₹15 Cr; Order Book Surges to ₹946 Cr
Prostarm Info Systems reported a stellar Q3 FY26 with revenue growing 110% YoY to ₹161 crores and PAT increasing 101% to ₹15 crores. The company's order book stands robust at ₹946 crores, providing strong revenue visibility for the next 18 months. Management highlighted that the company is now effectively net debt-free, with long-term debt reduced to just ₹1.5 crore. Expansion plans are on track with a new 1.2 GW BESS facility in Jhajjar expected to be operational by Q4 FY26.
Key Highlights
Q3 Revenue surged 110% YoY to ₹161 crores, driven by large-scale project executions.
Order book reached ₹946 crores across 91 projects, with an additional ₹775 crores in the bidding pipeline.
Company is effectively net debt-free as long-term debt decreased from ₹3.4 crore to ₹1.5 crore.
New 1.2 GW BESS manufacturing facility in Jhajjar is nearing commissioning in Q4 FY26.
EBITDA margins for Q3 stood at 12.65%, with management targeting a sustainable range of 12-15%.
👀 What to Watch
Investors should monitor the commissioning of the Jhajjar facility and the conversion of the ₹775 crore bid pipeline into firm orders. The strong order book and debt-free status make it a compelling growth story in the power electronics and energy storage sector.
Strides Pharma Subsidiary Completes 100% Acquisition of Neviton Softech for ₹21.77 Cr
Strides Pharma's wholly-owned subsidiary, Arco Lab, has acquired the remaining 50% stake in Neviton Softech for approximately ₹21.77 crores (Euro 2 million). Neviton, which specializes in IT services and IoT-based engineering solutions, reported a turnover of ₹27.08 crores and a PAT of ₹4.26 crores for FY25. This acquisition consolidates Neviton as a step-down subsidiary, following a phased investment strategy that began in 2022. The move is strategically aimed at enhancing Strides' internal digitization and driving operational cost efficiencies.
Key Highlights
Acquisition of the final 50% equity interest in Neviton Softech for a cash consideration of ~₹21.77 crores.
Neviton reported a steady financial performance with FY25 turnover of ₹27.08 crores and PAT of ₹4.26 crores.
Target company specializes in high-tech areas including IoT devices and real-time data integration for engineering solutions.
Strategic integration with Arco Lab is expected to yield significant cash savings and enable better group-wide digitization.
👀 What to Watch
This is a strategic bolt-on acquisition that strengthens the company's internal IT and digital capabilities at a reasonable valuation. Investors should monitor how these technological synergies contribute to long-term operational margin improvements.
IndoStar Q3 FY26: Disbursements Up 20% QoQ to ₹1,117 Cr; Vehicle Finance Leads Growth
IndoStar Capital Finance reported a 20% sequential growth in disbursements to ₹1,117 crores for Q3 FY26, driven primarily by the vehicle finance segment. The company's total AUM reached ₹7,692 crores, while Net Interest Income grew 16.1% year-on-year to ₹209 crores. Asset quality showed significant improvement, with delinquency levels in the 2025 cohort being 50% lower than previous years. Management is focusing on retail-led growth through used vehicle finance and Micro LAP, supported by a digital-first approach.
Key Highlights
Total disbursements rose 20% QoQ to ₹1,117 crores, with vehicle finance contributing ₹1,087 crores.
Net Interest Income (NII) increased by 16.1% YoY to ₹209 crores for the quarter.
Asset quality improved significantly, with the 2025 cohort showing 50% lower delinquency levels than previous cohorts.
Micro LAP segment AUM reached ₹128 crores with a collection efficiency near 100% and only 6 customers in 1+ DPD.
Completed preferential allotment of 2.5 crore shares to promoters and Florintree upon warrant conversion.
👀 What to Watch
Investors should monitor the continued scale-up of the high-yield Micro LAP business and the impact of new leadership on vehicle finance margins. The improved asset quality of recent cohorts suggests a lower credit cost trajectory ahead.
Prostarm Info Systems Reports 9M FY26 Revenue of ₹2,813 Mn with ₹9,460 Mn Order Book
Prostarm Info Systems Limited showcased strong growth in its Q3 & 9M FY26 investor presentation, reporting an operating income of INR 2,813 Mn for the nine-month period. The company maintains a robust order book of INR 9,460 Mn, which is significantly higher than its annual revenue, providing high growth visibility. Key performance indicators remain healthy with an ROE of 27.82% and ROCE of 40.81%. Significant expansion is underway with a new 1.2 GWH BESS facility in Haryana expected to be operational by Q4-FY26 and a Gujarat unit in Q1-FY27.
Key Highlights
Total order book stands at a significant INR 9,460 Mn as of February 2026
Reported 9M-FY26 operating income of INR 2,813 Mn with an EBITDA margin of 12.55%
Strong historical growth with a 3-year Revenue CAGR of 26.97% and PAT CAGR of 38.41%
Expanding manufacturing footprint with a 1.2 GWH BESS unit in Haryana (Q4-FY26) and a new UPS unit in Gujarat (Q1-FY27)
Secured major BESS orders from Adani Electricity, Bihar State Power, and KPTCL
👀 What to Watch
Investors should monitor the timely commissioning of the new BESS and UPS facilities, as these are critical for executing the massive ₹9,460 Mn order book. The company's entry into the high-growth BESS segment and its strong return ratios make it a key player to watch in the power conditioning space.
Melstar Reports Zero Revenue and ₹20.31 Lakh Loss in Q3 FY26; CFO Appointed
Melstar Information Technologies reported zero revenue for the quarter ended December 31, 2025, as it continues to struggle post-insolvency proceedings. The company recorded a net loss of ₹20.31 lakhs for the quarter, while the nine-month loss widened significantly to ₹118.41 lakhs from ₹29.95 lakhs in the previous year. Statutory auditors have issued a qualified opinion, raising concerns about the company's ability to continue as a 'going concern' given the lack of operations and reliance on future business licenses. Management has been restructured with the formal appointment of Raveendra Sangapu as CFO and Rose Mary Vase as an Independent Director.
Key Highlights
Reported zero revenue from operations and zero other income for both Q3 FY26 and the nine-month period.
Net loss for Q3 FY26 stood at ₹20.31 lakhs, compared to a loss of ₹23.07 lakhs in the same quarter last year.
Nine-month (9M) net loss surged to ₹118.41 lakhs, a sharp increase from the ₹29.95 lakh loss reported in 9M FY25.
Auditors issued a qualified conclusion citing the company's history of corporate insolvency and lack of current business activity.
Board approved the appointment of Raveendra Sangapu as CFO and Rose Mary Vase as an Additional Independent Director.
👀 What to Watch
Investors should remain highly cautious as the company has no operational revenue and faces significant 'going concern' risks. The stock is speculative until there is clear evidence of business licenses being obtained and operations restarting.
Melstar Reports Zero Revenue in Q3 FY26; Appoints New CFO and Independent Director
Melstar Information Technologies reported zero revenue for the quarter ended December 31, 2025, resulting in a net loss of ₹20.31 lakhs. The company is currently in a post-insolvency phase under new management and is awaiting necessary business licenses to commence operations. Key leadership changes include the appointment of Mr. Raveendra Sangapu as CFO and Ms. Rose Mary Vase as an Independent Director. The statutory auditors have issued a qualified opinion, noting that the company's status as a going concern is dependent on the successful execution of its new business plan.
Key Highlights
Reported zero revenue from operations for both the quarter and nine-month period ended December 31, 2025.
Net loss for the quarter stood at ₹20.31 lakhs, while the nine-month loss reached ₹118.41 lakhs.
Appointed Ms. Rose Mary Vase as an Additional Independent Director for a five-year term.
Promoted Mr. Raveendra Sangapu to the position of Chief Financial Officer (KMP).
Auditors issued a qualified conclusion due to the company's history of insolvency and lack of current operational revenue.
👀 What to Watch
Investors should exercise extreme caution as the company is currently non-operational and its future depends entirely on obtaining regulatory clearances to restart business activities. The stock remains highly speculative following its emergence from the Corporate Insolvency Resolution Process.
Melstar Reports Zero Revenue and ₹20.31 Lakh Net Loss in Q3 FY26; Appoints New CFO
Melstar Information Technologies reported zero revenue from operations for the quarter ended December 31, 2025, as it continues to await business licenses to restart operations. The company posted a net loss of ₹20.31 lakhs for the quarter, which is an improvement over the ₹53.84 lakhs loss in the preceding quarter. Statutory auditors have issued a qualified opinion, noting that the company's financial results are prepared on a 'going concern' basis despite historical insolvency proceedings and current lack of operations. The board also announced the appointment of Raveendra Sangapu as Chief Financial Officer and Rose Mary Vase as an Independent Director.
Key Highlights
Reported zero revenue from operations and zero other income for the quarter ended December 31, 2025.
Net loss for the quarter stood at ₹20.31 lakhs, compared to a loss of ₹23.07 lakhs in the same period last year.
Cumulative net loss for the nine-month period ended December 31, 2025, reached ₹118.41 lakhs.
Auditors highlighted a qualified conclusion regarding the 'going concern' status as the company is still awaiting licenses to commence business.
Board approved the appointment of Mr. Raveendra Sangapu as CFO and Ms. Rose Mary Vase as an Additional Independent Director.
👀 What to Watch
Investors should remain highly cautious as the company has no operational revenue and is currently surviving on a 'going concern' assumption post-insolvency. It is advisable to wait for actual revenue generation and the receipt of necessary business licenses before considering any investment.
Sanstar Q3 FY26 PAT Recovers to ₹137 Mn; Dhule Expansion to Commission in Feb 2026
Sanstar Limited reported a sequential recovery in Q3 FY26 with revenue of ₹2,018 million and a PAT of ₹137 million, following a volatile first half. EBITDA margins improved significantly to 8.9% in Q3 from a low of 0.7% in Q2, driven by higher plant utilization and better cost control. However, 9M FY26 performance remains subdued with revenue down 22.3% YoY to ₹5,679 million due to pricing pressure from Chinese exports in Southeast Asia. The company's major capacity expansion at Dhule is on track, with the native starch plant expected to commission by late February 2026.
Key Highlights
Q3 FY26 Revenue stood at ₹2,018 million, reflecting a 2.7% sequential growth over Q2.
EBITDA recovered to ₹179 million in Q3 from ₹14 million in Q2, with margins reaching 8.9%.
9M FY26 Revenue declined 22.3% YoY to ₹5,679 million, impacted by global pricing headwinds.
Dhule expansion to 2,100 TPD is nearing completion, with the native starch unit set for Q4 FY26 commissioning.
Exports contributed ₹644 million to Q3 revenue, serving 58 countries despite Chinese competition.
👀 What to Watch
Investors should focus on the successful commissioning and ramp-up of the Dhule expansion in Q4 FY26, which is critical for future volume growth. While sequential recovery is positive, the impact of Chinese export intensity on global starch realizations remains a key risk to monitor.
Sanstar Q3 FY26 Net Profit at ₹13.67 Cr; Sequential Recovery but 9M Profit Down 63% YoY
Sanstar Limited reported a strong sequential recovery in the quarter ended December 31, 2025, with net profit rising to ₹13.67 crore from a low of ₹0.63 crore in Q2 FY26. However, the year-on-year performance remains weak, with Q3 revenue declining 8.9% to ₹201.76 crore. For the nine-month period (9M FY26), net profit has fallen sharply to ₹13.96 crore compared to ₹38.28 crore in the previous year. On a positive note, finance costs have reduced significantly following the repayment of ₹100 crore in borrowings using IPO proceeds.
Key Highlights
Net Profit for Q3 FY26 stood at ₹13.67 crore, recovering from ₹0.63 crore in the previous quarter.
Revenue from operations for Q3 FY26 was ₹201.76 crore, down from ₹221.42 crore in Q3 FY25.
9M FY26 Net Profit dropped to ₹13.96 crore from ₹38.28 crore in 9M FY25, a 63.5% decline.
Finance costs for 9M FY26 decreased to ₹1.72 crore from ₹6.72 crore YoY due to debt repayment.
Company has utilized ₹357.23 crore of IPO proceeds, with ₹181.56 crore spent on the Dhule plant expansion.
👀 What to Watch
While the sequential recovery in margins is encouraging, the significant year-on-year decline in 9M profitability warrants caution. Investors should monitor the impact of the Dhule plant expansion on future revenue growth.
Star Paper Mills Q3 FY26: Net Profit at ₹8.22 Cr Driven by Other Income; Revenue Down 5.8% YoY
Star Paper Mills reported a mixed Q3 FY26 with Net Profit rising 6.6% YoY to ₹8.22 crore, despite a 5.8% decline in revenue from operations to ₹91.82 crore. The profitability was heavily supported by a significant spike in 'Other Income' which reached ₹11.80 crore, offsetting an operational loss as total expenses (₹93.05 crore) exceeded revenue. Sequentially, net profit saw a sharp decline of 36.9% from ₹13.02 crore in Q2 FY26. For the nine-month period ended Dec 2025, net profit stands at ₹34.03 crore compared to ₹36.13 crore in the previous year.
Key Highlights
Revenue from operations fell 5.8% YoY to ₹91.82 crore from ₹97.48 crore in Q3 FY25.
Net Profit for the quarter stood at ₹8.22 crore, up from ₹7.71 crore YoY but down from ₹13.02 crore QoQ.
Other Income surged to ₹11.80 crore, which was the primary driver of the ₹10.57 crore Profit Before Tax.
Raw material costs remained the largest expense at ₹58.27 crore, while power and fuel costs stood at ₹15.34 crore.
Basic EPS for the quarter was ₹5.26, compared to ₹4.94 in the corresponding quarter of the previous year.
👀 What to Watch
Investors should be cautious as the company's core operations were loss-making this quarter, with profitability entirely dependent on non-operating income. Monitor the sustainability of revenue growth and raw material cost trends in the upcoming quarters before making new positions.
Prostarm Info Systems Q3 Standalone PAT Jumps 105% YoY to ₹15.96 Crore
Prostarm Info Systems reported a robust performance for Q3 FY26, with standalone revenue from operations surging 110.8% year-on-year to ₹159.34 crore. Standalone net profit followed suit, doubling to ₹15.96 crore compared to ₹7.79 crore in the same period last year. On a consolidated basis, the nine-month revenue reached ₹281.31 crore, showing steady growth over the previous year's ₹268.63 crore. The company maintains its focus on customized power electronic solutions, which remains its sole reportable business segment.
Key Highlights
Standalone Revenue from operations grew 110.8% YoY to ₹159.34 crore in Q3 FY26.
Standalone Net Profit increased by 104.9% YoY to ₹15.96 crore from ₹7.79 crore.
Quarter-on-quarter (QoQ) standalone revenue saw a massive jump from ₹64.61 crore in Q2 FY26.
Standalone Earnings Per Share (EPS) for the quarter rose to ₹2.88 from ₹1.82 YoY.
Consolidated 9-month revenue stood at ₹281.31 crore, up from ₹268.63 crore in the previous year period.
👀 What to Watch
The significant jump in quarterly revenue and profitability suggests strong execution and demand in the power electronics segment. Investors should monitor the sustainability of these margins and the order book to determine if this represents a permanent shift in the company's growth trajectory.
Prostarm Info Systems Declared L-1 Bidder for INR 4.29 Crore WBMSC Project
Prostarm Info Systems Limited has been declared the L-1 bidder for a contract from West Bengal Medical Services Corporation (WBMSC). The project involves the supply, installation, and commissioning of 10 KVA UPS systems and batteries at 137 Block Primary Health Units across West Bengal. The total contract value is INR 4.29 Crores, with an execution timeline of 180 days. This order includes a 3-year warranty on the equipment, strengthening the company's service portfolio in the public healthcare sector.
Key Highlights
Total contract value is approximately INR 4.29 Crores
Project covers 137 Block Primary Health Units across the state of West Bengal
Execution period is set for 180 days from the date of award
Scope includes supply, installation, testing, and commissioning of 10 KVA UPS systems
Contract includes a comprehensive 3-year warranty on both UPS and batteries
👀 What to Watch
Investors should track the timely execution of this 180-day project as it provides short-term revenue visibility. Continued success in securing government healthcare infrastructure contracts could be a positive growth driver for the company.
Star Health Appoints Himanshu Walia and Amitabh Jain as Whole-time Directors for 5 Years
Star Health has received IRDAI approval to appoint Mr. Himanshu Walia and Mr. Amitabh Jain as Whole-time Directors and Key Managerial Personnel for a five-year term starting February 11, 2026. Mr. Walia, the current Chief Marketing Officer, has been with the company since 2007 and brings over 22 years of insurance experience. Mr. Jain, the current Chief Operating Officer and a former founding member of ICICI Lombard, has over 25 years of experience in financial services. These appointments strengthen the leadership team by elevating experienced internal executives to the board level.
Key Highlights
Appointment of two Whole-time Directors for a fixed term of 5 years effective February 11, 2026
Mr. Himanshu Walia (CMO) brings 22+ years of experience and has been with Star Health since 2007
Mr. Amitabh Jain (COO) has 25+ years of experience and was a founding member of ICICI Lombard
Appointments have received formal regulatory approval from IRDAI
👀 What to Watch
Investors should view this as a positive move for leadership continuity and operational stability. Monitor the company's execution on digital transformation and market share growth under this strengthened leadership team.
Star Cement Q3 FY26 PAT Jumps to ₹74 Cr; EBITDA Per Ton Rises to ₹1,600
Star Cement reported a robust performance for Q3 FY26, with revenue growing 22.4% YoY to ₹880 crores. The company's EBITDA per ton saw a significant jump to ₹1,600 compared to ₹1,000 in the previous year, driven by improved realizations in the Northeast market. Net profit surged to ₹74 crores from ₹9 crores YoY, despite a 28% drop in subsidy income. Management confirmed the commissioning of the Silchar plant in February 2026, which is expected to bolster future volumes and subsidy benefits.
Key Highlights
Revenue increased to ₹880 crores from ₹719 crores YoY, while PAT surged to ₹74 crores from ₹9 crores.
EBITDA per ton improved significantly to ₹1,600 from ₹1,000 in the same quarter last year.
Total cement sales volume grew to 12.31 lakh tons, with Northeast sales accounting for 9.36 lakh tons.
Silchar plant commissioning is scheduled for February 2026, with subsidy benefits expected to kick in after 7-8 months.
Incentive income dropped 28% YoY to ₹33 crores following the GST rate reduction from 28% to 18%.
👀 What to Watch
Investors should consider the strong operational efficiency and upcoming capacity expansion at Silchar as positive long-term catalysts. The company remains a dominant player in the Northeast, though monitoring logistics costs and the impact of new regional capacity is advised.
IndoStar Q3FY26: Disbursements Up 20% QoQ to ₹1,117 Cr; PPOP Grows 44% YoY
IndoStar Capital Finance reported strong operational growth in Q3FY26, with disbursements rising 20% QoQ to ₹1,117 crore and AUM reaching ₹7,692 crore. While Pre-provision operating profit (PPOP) surged 43.5% YoY to ₹85.2 crore, Profit After Tax (PAT) fell 27.7% YoY to ₹8.3 crore, primarily due to a one-time ₹4.8 crore regulatory wage code impact. The company demonstrated improved efficiency with a 67 bps YoY reduction in cost of funds to 10.09% and a 70 bps improvement in yields. Asset quality remains stable with Gross Stage 3 at 4.06% and a very healthy Capital Adequacy Ratio of 41.4%.
Key Highlights
Disbursements grew 20% QoQ to ₹1,117 crore, led by 21% growth in Vehicle Finance.
Pre-provision operating profit (PPOP) increased 43.5% YoY to ₹85.2 crore driven by yield expansion.
Cost of funds improved by 67 bps YoY to 10.09% through the 'LEAP' cost optimization initiative.
Standalone PAT of ₹8.3 crore includes a one-time ₹4.8 crore impact from regulatory changes in the Wage Code.
Capital Adequacy Ratio (CAR) stands strong at 41.4% with low leverage of 1.2x following warrant conversions.
👀 What to Watch
Investors should look past the one-time PAT dip and focus on the robust 44% YoY growth in operating profit and improving NIMs. The company's strong capital position and declining cost of funds suggest a positive trajectory for future profitability.
IndoStar Q3FY26: NIM Expands to 8.6% Despite PAT Dip to ₹8.3 Crore
IndoStar Capital Finance reported a PAT of ₹8.3 crore for Q3FY26, a decline from ₹11.4 crore in the previous year. While overall AUM saw a slight year-on-year dip to ₹7,692 crore, Net Interest Margins (NIM) showed significant improvement, rising to 8.6% from 5.4% a year ago. The company is successfully transitioning to a retail-centric model, with Micro LAP AUM growing over 6x to ₹128 crore. Asset quality remains a point of focus as Gross Stage 3 assets rose sequentially to 4.06% from 3.04% in Q2FY26.
Key Highlights
Net Interest Margin (NIM) improved significantly to 8.6% in Q3FY26 compared to 5.4% in Q3FY25.
Micro LAP segment showed robust growth with AUM reaching ₹128 crore, up from ₹19 crore in the previous year.
Capital Adequacy Ratio remains very healthy at 41.4%, providing a strong cushion for future growth.
Gross Stage 3 assets improved year-on-year to 4.06% but showed a sequential increase from 3.04% in Q2FY26.
Total disbursements for the quarter stood at ₹1,117 crore, showing a recovery from the previous quarter's ₹927 crore.
👀 What to Watch
Investors should monitor the sequential rise in Stage 3 assets and the impact of the retail transition on bottom-line profitability. While the strong capital position and improving NIMs are positive, consistent PAT growth is yet to materialize.
IndoStar Capital Finance Approves Q3 FY26 Results; Deploys ₹201 Cr for Growth
IndoStar Capital Finance has approved its unaudited financial results for the quarter and nine months ended December 31, 2025. The company disclosed the full utilization of approximately ₹201.33 crore raised through two preferential issues in late 2025. These funds were entirely directed toward growth objectives, specifically for onward lending in commercial vehicle, housing, and SME finance. The absence of any deviation in fund usage reflects management's commitment to expanding the core lending business.
Key Highlights
Approved Q3 and 9M FY26 unaudited standalone and consolidated financial results.
Utilized ₹149.99 crore raised on Nov 24, 2025, for onward lending and capital augmentation.
Utilized ₹51.33 crore raised on Dec 20, 2025, for growth objectives in retail and SME segments.
Reported zero deviation in the utilization of proceeds from preferential issues.
Trading window for designated persons to reopen on February 12, 2026.
👀 What to Watch
Investors should review the specific profit and NPA figures in the full results to assess the quality of the expanded loan book. The rapid deployment of capital indicates strong demand in their target lending segments.
IndoStar Capital Reports Nil Deviation in Utilization of Rs 201.3 Cr Raised via Warrants
IndoStar Capital Finance has confirmed zero deviation in the utilization of funds raised through preferential issues of warrants during the quarter ended December 31, 2025. The company raised approximately Rs 150 crore on November 24 and an additional Rs 51.3 crore on December 20, totaling over Rs 201 crore. All proceeds were deployed toward growth objectives, specifically for onward lending and augmenting the capital base. This transparency, monitored by CRISIL Ratings, reinforces management's commitment to its stated business expansion strategy.
Key Highlights
Confirmed NIL deviation in the utilization of Rs 201.33 crore raised via preferential issue of warrants.
Raised Rs 149.99 crore on Nov 24, 2025, and Rs 51.33 crore on Dec 20, 2025.
100% of the raised funds were utilized for 'Growth Objectives' including onward lending, exceeding the minimum 75% threshold.
CRISIL Ratings Limited acted as the monitoring agency, verifying the fund deployment.
Funds are being used to support commercial vehicle financing, housing finance, and SME lending portfolios.
👀 What to Watch
Investors should take confidence in the disciplined and transparent deployment of capital into the company's core lending business. Monitor the next few quarterly earnings to see how this capital infusion translates into AUM growth and interest income.
IndoStar Capital Approves Q3 Results and Reports Full Utilization of ₹201 Crore Growth Capital
IndoStar Capital Finance has approved its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The company reported the successful deployment of approximately ₹201.33 crore raised through preferential issues in late 2025. Notably, 100% of these funds were utilized for growth objectives and onward lending, exceeding the minimum 75% requirement. The board confirmed there were no deviations in the utilization of proceeds, indicating disciplined execution of its capital allocation strategy.
Key Highlights
Approved Unaudited Consolidated and Standalone Financial Results for Q3 and 9M FY2025-26.
Successfully utilized ₹149.99 crore raised via preferential issue on November 24, 2025, for growth objectives.
Deployed ₹51.33 crore raised via preferential issue on December 20, 2025, for onward lending and capital augmentation.
Achieved 100% fund utilization for core business growth, surpassing the mandated minimum threshold of 75%.
Confirmed zero deviation or variation in the use of funds as per the monitoring agency (CRISIL Ratings).
👀 What to Watch
Investors should examine the detailed financial statements to evaluate the company's margin trends and asset quality following the capital infusion. The full deployment of raised funds into lending suggests an aggressive growth phase that requires monitoring of credit costs.
